CDKN2B-AS1 and cancer: A meta-analysis on ANRIL with human cancer has been reported, but one focused on lymph node metastasis (LNM) and prognosis in human cancer,[7] in another in 2016 included only 6 studies.[8] With the increase in lncRNA research, many studies of ANRIL in human cancer have been reported.